Allogenic expanded Natural Killer Cells (AlloNK1)
2024-2264
Phase 2 mab active
Quick answer
Allogenic expanded Natural Killer Cells (AlloNK1) for Nasopharyngeal Carcinoma (NPC) is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Nasopharyngeal Carcinoma (NPC)
- Phase
- Phase 2
- Modality
- mab
- Status
- active